Paul Sauer, SVP Process Development, Manufacturing at Vaxcyte, Inc. (PCVX), sold 4,684 shares at $26.56 ($125K) on 2021-02-11, disclosed to the SEC on 2021-02-16.
Open-market sale of $125k PCVX by SVP Process Development, Manufacturing. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.56 | 2,184 | $58K | 46.5% |
| 2 | $26.56 | 2,184 | $58K | 46.5% |
| 3 | $27.27 | 316 | $9K | 6.9% |
| Total | $26.61 avg | 4,684 | $125K | 100% |
| Filing → |
| PCVX | SELL | 2022-07-22 | $75K | — | Filing → |
| PCVX | SELL | 2022-05-25 | $79K | — | Filing → |
| PCVX | SELL | 2022-04-26 | $75K | — | Filing → |